Photo of Hakon Blomstrand

Hakon Blomstrand

Publications

2026

Hanna Lagenfelt, Hakon Blomstrand, Emma Gransmark, Nils Elander (2026) Real-world evidence on second line chemotherapy in advanced biliary tract carcinoma refractory to gemcitabine and oxaliplatin (GemOx) BMC Cancer, Vol. 26, Article 496 (Article in journal) https://dx.doi.org/10.1186/s12885-026-16009-y
Christoforos Spyretos, Juan Manuel Pardo Ladino, Hakon Blomstrand, Per Nyman, Oscar Snödahl, Alia Shamikh, Nils Elander, Neda Haj-Hosseini (2026) Quantification of Ki-67 labeling index in pediatric brain tumor immunohistochemistry images Journal of Neuropathology and Experimental Neurology (Article in journal) https://dx.doi.org/10.1093/jnen/nlaf163

2025

Hakon Blomstrand, Erik Tesselaar, Bergthor Björnsson, Wolf Bartholomä, Tomas Bjerner, Michael Sandborg, Nils Elander, Mischa Woisetschläger (2025) PCD-CT Versus EID-CT in Imaging of Pancreatic Ductal Adenocarcinoma: A Prospective Comparative Pilot Study Anticancer Research, Vol. 45, p. 1547-1558 (Article in journal) https://dx.doi.org/10.21873/anticanres.17536
Hakon Blomstrand, Malin Bodarve, Fredrik Groth, Peter Naredi, Malin Sund, Caroline Vilhav, Henrik Green, Bergthor Björnsson, Daniel Ohlund, Stina Lindblad, Oskar Franklin, Nils Elander (2025) Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine Oncology Letters, Vol. 29, Article 99 (Article in journal) https://dx.doi.org/10.3892/ol.2024.14845
Christoforos Spyretos, Juan Manuel Pardo Ladino, Hakon Blomstrand, Per Nyman, Oscar Snödahl, Alia Shamikh, Nils Elander, Neda Haj-Hosseini (2025) Automatic Quantification of Ki-67 Labeling Index in Pediatric Brain Tumors Using Qupath (Manuscript (preprint)) https://dx.doi.org/10.1101/2025.05.09.25327292

2024

Hakon Blomstrand (2024) Prognostic aspects of localised and metastatic pancreatic cancer (Doctoral thesis, comprehensive summary) https://dx.doi.org/10.3384/9789180756822
Linda Bojmar, Constantinos Zambirinis, Jonathan M. Hernandez, Jayasree Chakraborty, Lee Shaashua, Junbum Kim, Kofi Ennu Johnson, Samer Hanna, Gokce Askan, Jonas Burman, Hiranmayi Ravichandran, Jian Zheng, Joshua S. Jolissaint, Rami Srouji, Yi Song, Ankur Choubey, Han Sang Kim, Michele Cioffi, Elke van Beek, Carlie Sigel, Jose Jessurun, Paulina Velasco Riestra, Hakon Blomstrand, Carolin Jönsson, Anette Jönsson, Pernille Lauritzen, Weston Buehring, Yonathan Ararso, Dylanne Hernandez, Jessica P. Vinagolu-Baur, Madison Friedman, Caroline Glidden, Laetitia Firmenich, Grace Lieberman, Dianna L. Mejia, Naaz Nasar, Anders P. Mutvei, Doru M. Paul, Yaron Bram, Bruno Costa-Silva, Olca Basturk, Nancy Boudreau, Haiying Zhang, Irina R. Matei, Ayuko Hoshino, David Kelsen, Irit Sagi, Avigdor Scherz, Ruth Scherz-Shouval, Yosef Yarden, Moshe Oren, Mikala Egeblad, Jason S. Lewis, Kayvan Keshari, Paul M. Grandgenett, Michael A. Hollingsworth, Vinagolu K. Rajasekhar, John H. Healey, Bergthor Björnsson, Diane M. Simeone, David A. Tuveson, Christine A. Iacobuzio-Donahue, Jaqueline Bromberg, C. Theresa Vincent, Eileen M. O'Reilly, Ronald P. DeMatteo, Vinod P. Balachandran, Michael I. D'Angelica, T. Peter Kingham, Peter J. Allen, Amber L. Simpson, Olivier Elemento, Per A Sandström, Robert E. Schwartz, William R. Jarnagin, David Lyden (2024) Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer Nature Medicine, Vol. 30, p. 2170-2180 (Article in journal) https://dx.doi.org/10.1038/s41591-024-03075-7

2023

Hakon Blomstrand, Hans Olsson, Henrik Green, Bergthor Björnsson, Nils Elander (2023) Impact of resection margins and para-aortic lymph node metastases on recurrence patterns and prognosis in resectable pancreatic cancer - a long-term population-based cohort study HPB, Vol. 25, p. 1531-1544 (Article in journal) https://dx.doi.org/10.1016/j.hpb.2023.08.006

2021

Hakon Blomstrand, Atul Batra, Winson Y. Cheung, Nils Elander (2021) Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer World Journal of Clinical Oncology, Vol. 12, p. 787-799 (Article, review/survey) https://dx.doi.org/10.5306/wjco.v12.i9.787
Hanna Lagenfelt, Hakon Blomstrand, Nils Elander (2021) Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer Cancers, Vol. 13, Article 3507 (Article in journal) https://dx.doi.org/10.3390/cancers13143507

2020

Hakon Blomstrand, Karin Adolfsson, Per Sandström, Bergthor Björnsson (2020) Complete Radiologic Response of Metastatic Pancreatic Ductal Adenocarcinoma to Microwave Ablation Combined with Second-Line Palliative Chemotherapy Case Reports in Gastrointestinal Medicine, Vol. 2020, Article 4138215 (Article in journal) https://dx.doi.org/10.1155/2020/4138215
Hakon Blomstrand, Henrik Green, Mats Fredrikson, Emma Gransmark, Bergthor Björnsson, Nils Elander (2020) Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel BMC Cancer, Vol. 20, Article 950 (Article in journal) https://dx.doi.org/10.1186/s12885-020-07426-8
Emma Gränsmark, Nellie Bågenholm Bylin, Hakon Blomstrand, Mats Fredrikson, Elisabeth Åvall Lundqvist, Nils Elander (2020) Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer Frontiers in Oncology, Vol. 10, Article 1176 (Article in journal) https://dx.doi.org/10.3389/fonc.2020.01176

2019

Hakon Blomstrand, Ursula Scheibling, Charlotte Bratthall, Henrik Green, Nils Elander (2019) Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer BMC Cancer, Vol. 19, Article 40 (Article in journal) https://dx.doi.org/10.1186/s12885-018-5244-2

Research